Cannovum received its GMP manufacturing license

This means we can streamline our supply chain by packaging and labeling in Germany.

To the article
Download pdf

Mehr News

Other
July 2022

Cannovum AG part of the International Expert Hearings on Cannabis Legalization

Cannovum AG has participated in the consultation process of the German government for the legalization of cannabis for Adult-use.

Investment
April 2022

Cannovum AG resolves capital increase from authorized capital excluding subscription rights

The Management Board of Cannovum AG today resolved to increase the share capital.

Investment
February 2022

Cannovum AG launches Cannabis Medical Education Platform

Cannovum Medical Education (CME) is a free, comprehensive virtual continuing education platform for medical cannabis, in which the medical-therapeutic basics of medical cannabis are scientifically prepared.